Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc.

AVAHยทNASDAQ

$6.78

+4.8%
HealthcareMedical - Care Facilities

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

At a Glance

Live Snapshot
Market Cap$1.48B
EPS1.1000
P/E Ratio6.16
Earnings Date08/06/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is compressed (P/E 6.2).

Valuation inputs: P/E 6.2, earnings yield +16.2%, momentum +4.8%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is acceptable (ROE +1.2%, ROIC +16.3%).

Profitability stack: net margin +9.3%, ROE +1.2%, ROIC +16.3%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +90.4%, momentum +4.8%, net margin +9.3%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

avah

Aveanna Healthcare Holdings Inc. Market vs Earnings Trajectory

AVAH ยท NASDAQ

Loading price and EPS data...

Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc. Fair Value Envelope

AVAH ยท NASDAQ

Our analysis suggests that AVAH has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $6.78, this represents a potential HIDDEN relative to our calculated worth for Aveanna Healthcare Holdings Inc..

Intrinsic Value
Current Price: $6.78
3Y-131.0%
5Y-455.0%
10Y-523.0%
3Y+36.0%
5Y+63.0%
10Y+94.0%
3Y-134.0%
5Y-494.0%
10Y-577.0%
3Y+439.0%
5Y-1177.0%
10Y+466.0%
3Y+593.0%
5Y-520.0%
10Y+5591.0%
3Y+26.0%
5Y-13.0%
10Y+31.0%
Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc. Profit Bridge

AVAH ยท NASDAQ
Revenue2.43B
Cost of Goods Sold (1.63B)
Gross Profit805.15M
Operating Expenses (539.77M)
Operating Income265.38M
Interest Expense (140.09M)
Other Income/Expense-158.43M
Pretax Income106.95M
Income Tax (-118.09M)
Net Income225.03M
Net Income
225.03M

Profitability Analysis

Gross Margin

33.1%

Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.

Operating Margin

10.9%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

9.2%

Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.

Effective Tax Rate

-110.4%

Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.

Profitability Insight

Room for improvement: Moderate profitability with opportunities to enhance margins through better cost management or pricing strategy.

33.09%
Gross Profit Margin
5%
3Y+5.0%
5Y+2.0%
10Y+5.0%
10.91%
Operating Profit Margin
58%
3Y+2461.0%
5Y-607.0%
10Y+250.0%
9.25%
Net Profit Margin
-1813%
3Y-230.0%
5Y-233.0%
10Y-346.0%
115.72%
Return on Equity
1193%
3Y+10.0%
5Y-731.0%
10Y-947.0%
11.11%
Return on Assets
-1791%
3Y-233.0%
5Y-322.0%
10Y-465.0%
16.28%
Return on Invested Capital
-179%
3Y+2903.0%
5Y-1009.0%
10Y+498.0%
AVAH

Aveanna Healthcare Holdings Inc. Cash Conversion Engine

AVAH ยท NASDAQ
Net Income225.03M
Depreciation & Amortization28.22M
Stock-Based Compensation0.00
Change in Working Capital-52.66M
Others64.67M
Capital Expenditures-7.45M
Free Cash Flow114.79M

Cash Flow Quality Analysis

FCF Conversion Rate

51.0%

Weak cash conversion. Significant portion of earnings not converting to cashโ€”review working capital trends and capital intensity.

CapEx Intensity

6.1%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+336.2%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

-$52.66M

Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

avah

Aveanna Healthcare Holdings Inc. Funding & Solvency Profile

AVAH ยท NASDAQ
Cash & Cash Equivalents189.27M
Net Receivables335.60M
Inventory0.00
Other Current Assets26.63M
Total Current Assets575 M
Property, Plant & Equipment53.86M
Goodwill & Intangible Assets1.21B
Long-Term Investments38.43M
Other Non-Current Assets4.35M
Total Non-Current Assets97 M
Total Assets
2.02B

Financial Health Analysis

Current Ratio

1.47x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

7.40x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

185 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

28% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

avah

Aveanna Healthcare Holdings Inc. Street Expectations Map

AVAH ยท NASDAQ

Wall Street analysts project that AVAH stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 10.50, with estimates ranging from a low of 9.00 to a high of 13.00.

Lowest Target
9.00
32.74%
Consensus Target
10.50
54.87%
Highest Target
13.00
91.74%

The consensus 1-year price target stands at 10.50, with estimates ranging from a low of 9.00 to a high of 13.00.

Analyst Consensus Analysis

Upside Potential

+54.9%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

38.1% spread

Good consensus alignment. Moderate target spread reflects general agreement on value drivers with some variance in assumptions.

Analyst Conviction

High

Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

avah

Aveanna Healthcare Holdings Inc. Insider Positioning

AVAH ยท NASDAQ

During the last 12 months, insiders have sold $19.78M worth of AVAH shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

125.0K

948.54K

Net Activity

-949K

-$949K

3-6 Months

Bought

0

0.00

Sold

998.6K

7.57M

Net Activity

-7.6M

-$7.57M

6-9 Months

Bought

0

0.00

Sold

1.3M

11.27M

Net Activity

-11.3M

-$11.27M

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
VPR

Vigano Paul R

10 Percent Owner

1.3M sharesโ€ข1 transactions

$11.27M

2
SJ

Shaner Jeff

Officer: Chief Executive Officer

546.9K sharesโ€ข6 transactions

$4.10M

3
REC

Reisz Edwin C.

Officer: Chief Administrative Officer

213.0K sharesโ€ข6 transactions

$1.61M

4
CPA

Cunningham Patrick A.

Officer: Chief Compliance Officer

210.2K sharesโ€ข7 transactions

$1.60M

5
BM

Buckhalter Matthew

Officer: Chief Financial Officer

89.1K sharesโ€ข6 transactions

$697K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $19.78M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$949K

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

No Dividend Yield Data

AVAH has not reported any dividend yield values in the available annual periods.

ย 

avah Dividend History

AVAH
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%